PIONEERING EXONEURAL MEDICINES Trademark

Trademark Overview


On Tuesday, October 27, 2020, a trademark application was filed for PIONEERING EXONEURAL MEDICINES with the United States Patent and Trademark Office. The USPTO has given the PIONEERING EXONEURAL MEDICINES trademark a serial number of 90280802. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by Cygnal Therapeutics, Inc.. The PIONEERING EXONEURAL MEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
pioneering exoneural medicines

General Information


Serial Number90280802
Word MarkPIONEERING EXONEURAL MEDICINES
Filing DateTuesday, October 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements


Disclaimer with Predetermined Text"MEDICINES"
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCygnal Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameCygnal Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 9, 2021ASSIGNED TO LIE
Wednesday, December 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2021ASSIGNED TO EXAMINER
Thursday, September 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 31, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 31, 2021NON-FINAL ACTION WRITTEN
Saturday, March 27, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED